TORONTO — Dermatologists should prescribe emergency contraception (EC) to adolescent patients being treated with isotretinoin for acne.
That was one of the main messages from Andrea L. Zaenglein, MD, professor of dermatology and pediatrics, The Pennsylvania State University, Hershey, who discussed hormonal therapies for pediatric acne at the Society for Pediatric Dermatology (SPD) 2024 Annual Meeting.
Many doctors are reluctant to prescribe EC, which refers to contraceptive methods used to prevent unintended pregnancy after unprotected sexual intercourse or contraceptive failure, whether that’s from discomfort with EC or lack of training, Zaenglein told Medscape Medical News.
Isotretinoin, a retinoid marketed as Accutane and other brand names, is an effective treatment for acne but carries serious teratogenicity risks; the iPLEDGE Risk Evaluation and Mitigation Strategy is designed to manage this risk and minimize fetal exposure. Yet from 2011 to 2017, 210-310 pregnancies per year were reported to the US Food and Drug Administration, according to a 2019 study in JAMA Dermatology.
There is a knowledge gap regarding EC among dermatologists who prescribe isotretinoin, which “is perpetuated by the iPLEDGE program because it is inadequate in guiding clinicians or educating patients about the use of EC,” Zaenglein and colleagues wrote in a recently published viewpoint on EC prescribing in patients on isotretinoin.
Types of EC include oral levonorgestrel (plan B), available over the counter; oral ulipristal acetate (ella), which requires a prescription; and the copper/hormonal intrauterine device.
Not all teens taking isotretinoin can be trusted to be sexually abstinent. Zaenglein cited research showing 39% of female high school students have had sexual relations. “In my opinion, these patients should have emergency contraception prescribed to them as a backup,” she said.
Zaenglein believes there’s a fair amount of “misunderstanding” about EC, with many people thinking it’s an abortion pill. “It’s a totally different medicine. This is contraception; if you’re pregnant, it’s not going to affect your fetus.”
Outgoing SPD President Sheilagh Maguiness, MD, professor of dermatology and pediatrics, University of Minnesota, Minneapolis, agreed that Zaenglein raised an important issue. “She has identified a practice gap and a knowledge gap that we need to address,” she told Medscape Medical News.
When discussing contraception with female patients taking isotretinoin, assume they’re sexually active or could be, Zaenglein told meeting attendees. Be explicit about the risks to the fetus and consider their past compliance, she advised.
Complex Disorder
During her presentation, Zaenglein described acne as a “very complex, multifactorial inflammatory disorder” of the skin. It involves four steps: Increased sebum production, hyperkeratinization, Cutibacterium acnes, and inflammation. External factors such as diet, genes, and the environment play a role.
“But at the heart of all of it is androgens; if you didn’t have androgens, you wouldn’t have acne.” That’s why some acne treatments block androgen receptors.
Clinicians are increasingly using one such therapy, spironolactone, to treat acne in female adolescents. Zaenglein noted a Mayo Clinic study of 80 patients (mean age, 19 years), who had moderate to severe acne treated with a mean dose of 100 mg/d, that found 80% had improvement with a favorable side effect profile. This included nearly 23% who had a complete response (90% or more) and 36% who had a partial response (more than 50%); 20% had no response.
However, response rates are higher in adults, said Zaenglein, noting that spironolactone works “much better” in adult women.
Side effects of spironolactone can include menstrual disturbances, breast enlargement and tenderness, and premenstrual syndrome–like symptoms.
Dermatologists should also consider combined oral contraceptives (COCs) in their adolescent patients with acne. These have an estrogen component as well as a progestin component.
They have proven effectiveness for acne in adolescents, yet a US survey of 170 dermatology residents found only 60% felt comfortable prescribing them to healthy adolescents. The survey also found only 62% of respondents felt adequately trained on the efficacy of COCs, and 42% felt adequately trained on their safety.
Contraindications for COCs include thrombosis, migraine with aura, lupus, seizures, and hypertension. Complex valvular heart disease and liver tumors also need to be ruled out, said Zaenglein.
One of the “newer concerns” with COCs is depression, she said. “There’s biological plausibility because, obviously, hormones impact the brain.”
Preventing Drug Interactions
Before prescribing hormonal therapy, clinicians should carry out an acne assessment, aimed in part at preventing drug interactions. “The one we mostly have to watch out for is rifampin,” an antibiotic that could interact with COCs, said Zaenglein.
The herbal supplement St John’s Wort can reduce the efficacy of COCs. “You also want to make sure that they’re not on any medicines that will increase potassium, such as ACE inhibitors,” said Zaenglein. But tetracyclines, ampicillin, or metronidazole are usually “all okay” when combined with COCs, she added.
It’s important to get baseline blood pressure levels and to check these along with weight on a regular basis, said Zaenglein.
Always Consider Polycystic Ovarian Syndrome (PCOS)
Before starting hormonal therapy, she advises dermatologists to “always consider” PCOS, a condition that’s “probably much underdiagnosed.” Acne is common in adolescents with PCOS. She suggests using a PCOS checklist, a reminder to ask about irregular periods, hirsutism, signs of insulin resistance such as increased body mass index, a history of premature adrenarche, and a family history of PCOS, said Zaenglein, noting that a person with a sibling who has PCOS has about a 40% chance of developing the condition.
“We play an important role in getting kids diagnosed at an early age so that we can make interventions because the impact of the metabolic syndrome can have lifelong effects on their cardiovascular system, as well as infertility.”
Zaenglein is a member of the American Academy of Dermatology (AAD) Acne Guidelines work group, the immediate past president of the American Acne and Rosacea Society, a member of the AAD iPLEDGE work group, co–editor in chief of Pediatric Dermatology, an advisory board member of Ortho Dermatologics, and a consultant for Church & Dwight. Maguiness had no relevant conflicts of interest.
Source link : https://www.medscape.com/viewarticle/consider-emergency-contraception-teens-acne-2024a1000d4q?src=rss
Author :
Publish date : 2024-07-17 13:08:51
Copyright for syndicated content belongs to the linked Source.